Epigenetic bystander-like effects of stroke in somatic organs

Aging

Volumn 4, Issue 3, 2012, Pages 224-234

  Kovalchuk, Anna ^a   Lowings, Michael ^a   Rodriguez Juarez, Rocio ^a   Muhammad, Arif ^a   Ilnytskyy, Slava ^a   Kolb, Bryan ^a   Kovalchuk, Olga ^a  

^a UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Acetylation; Disease; Methylation; Stroke

Indexed keywords

EID: 84863331817     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100447     Document Type: Article

References (53)

1. Donnan GA, Fisher M, Macleod M and Davis SM. Stroke. Lancet. 2008; 371:1612-1623.
2. Eriksson D and Stigbrand T. Radiation-induced cell death mechanisms. Tumour Biol. 2010; 31:363-372.
3. Ferrer I. Cell death in the normal developing brain, and following ionizing radiation, methyl-azoxymethanol acetate, and hypoxia-ischaemia in the rat. Neuropathol Appl Neurobiol. 1996; 22:489-494.
4. Morgan WF and Sowa MB. Non-targeted bystander effects induced by ionizing radiation. Mutat Res. 2007; 616:159-164.
5. Hodny Z, Hubackova S and Bartek J. Cytokines shape chemotherapy-induced and 'bystander' senescence. Aging (Albany NY). 2010; 2:375-376.
6. Kovalchuk O and Baulch JE. Epigenetic changes and nontargeted radiation effects--is there a link? Environ Mol Mutagen. 2008; 49:16-25.
7. Brooks AL. Evidence for 'bystander effects' in vivo. Hum Exp Toxicol. 2004; 23:67-70.
8. Koturbash I, Boyko A, Rodriguez-Juarez R, McDonald RJ, Tryndyak VP, Kovalchuk I, Pogribny IP and Kovalchuk O. Role of epigenetic effectors in maintenance of the long-term persistent bystander effect in spleen in vivo. Carcinogenesis. 2007; 28:1831-1838.
9. Bird A. Perceptions of epigenetics. Nature. 2007; 447:396-398.
10. Feinberg AP. The epigenetics of cancer etiology. Semin Cancer Biol. 2004; 14:427-432.
11. Klose RJ and Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006; 31:89-97.
12. Jaenisch R and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003; 33 Suppl:245-254.
13. Rountree MR, Bachman KE, Herman JG and Baylin SB. DNA methylation, chromatin inheritance, and cancer. Oncogene. 2001; 20:3156-3165.
14. Goll MG and Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem. 2005; 74:481-514.
15. Agrawal A, Tay J, Yang GE, Agrawal S and Gupta S. Ageassociated epigenetic modifications in human DNA increase its immunogenicity. Aging (Albany NY). 2010; 2:93-100.
16. Koch CM and Wagner W. Epigenetic-aging-signature to determine age in different tissues. Aging (Albany NY). 2011; 3:1018-1027.
17. Murgatroyd C, Wu Y, Bockmuhl Y and Spengler D. The Janus face of DNA methylation in aging. Aging (Albany NY). 2010; 2:107-110.
18. Jenuwein T and Allis CD. Translating the histone code. Science. 2001; 293:1074-1080.
19. Schellenberg A, Lin Q, Schuler H, Koch CM, Joussen S, Denecke B, Walenda G, Pallua N, Suschek CV, Zenke M and Wagner W. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY). 2011; 3:873-888.
20. Cheung P and Lau P. Epigenetic regulation by histone methylation and histone variants. Mol Endocrinol. 2005; 19:563-573.
21. Saha A, Wittmeyer J and Cairns BR. Chromatin remodelling: the industrial revolution of DNA around histones. Nat Rev Mol Cell Biol. 2006; 7:437-447.
22. Dickey JS, Zemp FJ, Martin OA and Kovalchuk O. The role of miRNA in the direct and indirect effects of ionizing radiation. Radiat Environ Biophys. 2011; 50:491-499.
23. Sevignani C, Calin GA, Siracusa LD and Croce CM. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 2006; 17:189-202.
24. Mack GS. MicroRNA gets down to business. Nat Biotechnol. 2007; 25:631-638.
25. Jensen DK and Lal A. Micromanaging senescence. Aging (Albany NY). 2010; 2:322-323.
26. Gonzalez CL, Whishaw IQ and Kolb B. Complete sparing of spatial learning following posterior and posterior plus anterior cingulate cortex lesions at 10 days of age in the rat. Neuroscience. 2003; 122:563-571.
27. Schubeler D. Epigenomics: Methylation matters. Nature. 2009; 462:296-297.
28. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M and Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet. 2007; 39:457-466.
29. Dhasarathy A and Wade PA. The MBD protein family-reading an epigenetic mark? Mutat Res. 2008; 647:39-43.
30. Bartova E, Krejci J, Harnicarova A, Galiova G and Kozubek S. Histone modifications and nuclear architecture: a review. J Histochem Cytochem. 2008; 56:711-721.
31. Brenner C and Fuks F. A methylation rendezvous: reader meets writers. Dev Cell. 2007; 12:843-844.
32. Zacharias N, Sailhamer EA, Li Y, Liu B, Butt MU, Shuja F, Velmahos GC, de Moya M and Alam HB. Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells. Resuscitation. 2010.
33. Sayyed SG, Gaikwad AB, Lichtnekert J, Kulkarni O, Eulberg D, Klussmann S, Tikoo K and Anders HJ. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol Dial Transplant. 2010; 25:1811-1817.
34. van Riggelen J, Yetil A and Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer. 2010; 10:301-309.
35. Kondoh N, Shuda M, Tanaka K, Wakatsuki T, Hada A and Yamamoto M. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Res. 2001; 21:2429-2433.
36. Sun Y, Xiong X, Zhao Y and He H. Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator. Oncogene. 2011; 30:1798-1811.
37. Yu Q, Li J, Tan J, Zhuang L, Banerjee B, Yang XJ, Chau JFL, Lee PL, Hande MP and Li BJ. Ribosomal protein s27-like, a p53-inducible modulator of cell fate in response to genotoxic stress. Cancer Research. 2007; 67:11317-11326.
38. Roth KS, Spencer PD, Moses LC and Carter BE. Delta-Aminolevulinic-Acid Dehydratase - Is There a Form Unique to Renal-Cortex. Enzyme. 1990; 43:17-25.
39. Oskarsson A and Fowler BA. Effects of Lead on the Heme Biosynthetic-Pathway in Rat-Kidney. Exp Mol Pathol. 1985; 43:409-417.
40. Neusser MA, Lindenmeyer M, Edenhofer I, Gaiser S, Kretzler M, Segerer S and Cohen CD. Intrinsic APRIL and BLyS production in human lupus nephritis (LN). Swiss Med Wkly. 2010; 140:8S-8S.
41. Cohen CD, Neusser MA, Lindenmeyer MT, Edenhofer I, Gaiser S, Kretzler M, Regele H and Segerer S. Intrarenal production of B-cell survival factors in human lupus nephritis. Modern Pathol. 2011; 24:98-107.
42. Gillies JK and Lorimer IA. Regulation of p27Kip1 by miRNA 221/222 in glioblastoma. Cell Cycle. 2007; 6:2005-2009.
43. le Sage C, Nagel R, Egan DA, Schrier M, Mesman E, Mangiola A, Anile C, Maira G, Mercatelli N, Ciafre SA, Farace MG and Agami R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007; 26:3699-3708.
44. Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng K. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 2010; 10:367.
45. Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, Richardson JA and Olson EN. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A. 2010; 107:4218-4223.
46. Dey N, Das F, Mariappan MM, Mandal CC, Ghosh-Choudhury N, Kasinath BS and Choudhury GG. MicroRNA-21 Orchestrates High Glucose-induced Signals to TOR Complex 1, Resulting in Renal Cell Pathology in Diabetes. J Biol Chem. 2011; 286:25586-25603.
47. Kim J, Jonasch E, Alexander A, Short JD, Cai S, Wen S, Tsavachidou D, Tamboli P, Czerniak BA, Do KA, Wu KJ, Marlow LA, Wood CG, et al. Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma. Clin Cancer Res. 2009; 15:81-90.
48. Wei Q, Bhatt K, He HZ, Mi QS, Haase VH and Dong Z. Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol. 2010; 21:756-761.
49. Sequeira-Lopez ML, Weatherford ET, Borges GR, Monteagudo MC, Pentz ES, Harfe BD, Carretero O, Sigmund CD and Gomez RA. The microRNA-processing enzyme dicer maintains juxtaglomerular cells. J Am Soc Nephrol. 2010; 21:460-467.
50. Saal S and Harvey SJ. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens. 2009; 18:317-323.
51. Kato M, Arce L and Natarajan R. MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol. 2009; 4:1255-1266.
52. Schiller A and Covic A. Kidney and brain--a renal perspective of 'Les Liaisons Dangereuses'. Nephrol Dial Transplant. 2010; 25:1370-1373.
53. Covic A, Schiller A, Mardare NG, Petrica L, Petrica M, Mihaescu A and Posta N. The impact of acute kidney injury on short-term survival in an Eastern European population with stroke. Nephrol Dial Transplant. 2008; 23:2228-2234.